Wu Adela, Weingart Jon D, Gallia Gary L, Lim Michael, Brem Henry, Bettegowda Chetan, Chaichana Kaisorn L
Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Department of Neurosurgery, Neuro-Oncology Outcomes Laboratory, Johns Hopkins University, Baltimore, Maryland, USA.
World Neurosurg. 2017 Aug;104:120-128. doi: 10.1016/j.wneu.2017.05.028. Epub 2017 May 13.
Metastatic brain tumors are the most common brain tumors in adults. Patients with metastatic brain tumors have poor prognoses with median survival of 6-12 months. Seizures are a major presenting symptom and cause of morbidity and mortality. In this article, risk factors for the onset of preoperative seizures and postoperative seizure control are examined.
Adult patients who underwent resection of one or more brain metastases at a single institution between 1998 and 2011 were reviewed retrospectively.
Of 565 patients, 114 (20.2%) patients presented with seizures. Factors independently associated with preoperative seizures were preoperative headaches (P = 0.044), cognitive deficits (P = 0.031), more than 2 intracranial metastatic tumors (P = 0.013), temporal lobe location (P = 0.031), occipital lobe location (P = 0.010), and bone involvement by tumor (P = 0.029). Factors independently associated with loss of seizure control after surgical resection were preoperative seizures (P = 0.001), temporal lobe location (P = 0.037), lack of postoperative chemotherapy (P = 0.010), subtotal resection of tumor (P = 0.022), and local recurrence (P = 0.027). At last follow-up, the majority of patients (93.8%) were seizure-free. Thirty patients (5.30%) in total had loss of seizure control, and only 8 patients (1.41%) who did not have preoperative seizures presented with new-onset seizures after surgical resection of their metastases.
The brain is a common site for metastases from numerous primary cancers, such as breast and lung. The identification of factors associated with onset of preoperative seizures as well as seizure control postoperatively could aid management strategies for patients with metastatic brain tumors. Patients with preoperative seizures who underwent resection tended to have good seizure control after surgery.
转移性脑肿瘤是成人中最常见的脑肿瘤。转移性脑肿瘤患者预后较差,中位生存期为6至12个月。癫痫发作是主要的首发症状以及发病和死亡的原因。本文研究术前癫痫发作的危险因素以及术后癫痫控制情况。
回顾性分析1998年至2011年间在单一机构接受一个或多个脑转移瘤切除术的成年患者。
565例患者中,114例(20.2%)出现癫痫发作。与术前癫痫发作独立相关的因素有术前头痛(P = 0.044)、认知缺陷(P = 0.031)、颅内转移瘤超过2个(P = 0.013)、颞叶位置(P = 0.031)、枕叶位置(P = 0.010)以及肿瘤侵犯骨质(P = 0.029)。与手术切除后癫痫控制不佳独立相关的因素有术前癫痫发作(P = 0.001)、颞叶位置(P = 0.037)、术后未进行化疗(P = 0.010)、肿瘤次全切除(P = 0.022)以及局部复发(P = 0.027)。在最后一次随访时,大多数患者(93.8%)无癫痫发作。共有30例患者(5.30%)癫痫控制不佳,且仅有8例(1.41%)术前无癫痫发作的患者在转移瘤手术切除后出现新发癫痫发作。
脑是众多原发性癌症(如乳腺癌和肺癌)转移的常见部位。识别与术前癫痫发作及术后癫痫控制相关的因素有助于制定转移性脑肿瘤患者的管理策略。接受切除术的术前癫痫发作患者术后往往癫痫控制良好。